Hoffman Robert E.
SEC-identified person · CIK 1166288 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Fibrobiologics, Inc. FBLG | Director | filed 2024 - 2026 |
| Esperion Therapeutics, Inc. ESPR | Director | filed 2025 - 2026 |
| Cytodyn Inc. cydy | Chief Financial Officer | filed 2025 - 2026 |
| Tuhura Biosciences, Inc./NV KTRA | Director · President, CEO, and CFO | filed 2018 - 2026 |
| Zeta Acquisition Corp III KURO | Director | filed 2015 - 2021 |
| Versartis, Inc. VSAR | Director | filed 2018 - 2020 |
| Heron Therapeutics, INC. /DE/ appa | CFO & SVP, Finance | filed 2017 - 2019 |
| Combimatrix Corp CBMXD | Director | filed 2013 - 2017 |
| Telik INC TELK | Director | filed 2014 - 2017 |
| North Horizon, Inc. NORHD | Chief Financial Officer | filed 2016 - 2016 |
| Arena Pharmaceuticals INC ARNA | VP, Finance and CFO | filed 2006 - 2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.